Aytu Biopharma (AYTU) Net Income towards Common Stockholders (QoQ) (2011 - 2025)
Aytu Biopharma (AYTU) Net Income towards Common Stockholders (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.45 Mn | -5.27 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.81% |
| Mar 31, 2025 | -56.10% |
| Dec 31, 2024 | -67.72% |
| Sep 30, 2024 | 130.75% |
| Jun 30, 2024 | -106.84% |
| Mar 31, 2024 | 28.61% |
| Dec 31, 2023 | -29.68% |
| Sep 30, 2023 | 73.67% |
| Jun 30, 2023 | 65.88% |
| Mar 31, 2023 | -7.58% |
| Dec 31, 2022 | -854.78% |
| Sep 30, 2022 | -110.07% |
| Jun 30, 2022 | 113.06% |
| Mar 31, 2022 | -361.47% |
| Dec 31, 2021 | 58.54% |
| Sep 30, 2021 | -48.63% |
| Dec 31, 2020 | -121.20% |
| Sep 30, 2020 | 40.87% |
| Jun 30, 2020 | -36.57% |
| Mar 31, 2020 | 1.51% |